<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 115 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page114.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=115">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 115 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 115</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=115"><img src="../thumb/115.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>84 / 2020-04                                                            Autonomic - 5.2 / 5.3 / 5.4
   not est.in childr., diab.mellit.& hypoglycaem. as hypoglycaem.poss.exac-  Indications: Condit.req.anticholinerg.eff.  Dosage: Admin.with/without food, swallow whole. Recomm.dos:
   erbat.& concurr. tachycard.mask., ren.funct.impairm., hypotens. prior to   (S4) INJ. V/5.4/64, 65.   4 mg once dly. Dos.may be reduc.to 2 mg based on indiv.tolerabil.
   treatm., dos.&gt; 200 µg/kg/min (0,2 mg/kg/min) not recomm.as dos.relat.   798428-007: 0,5 mg/ml,10x1 ml amps, R30,51.  In pres.of imp.ren./hepat.funct.2 mg once dly.recomm. With keto-
   hypotens.poss., hypotens.usually resolv.&lt; 30 mins. once dos.reduc./  798436-018: 1 mg/ml, 10x1 ml amps, R40,91.  conazole/other potent cytochrome P450 3A4 inhibit: Recomm.
   infus.stopp, withdraw at first sign/ sympt.of card.fail.& consid.specif.  Dosage: Premed: 0,3-0,6 mg IV immed.prior to anaesth.  dly.dos: 2 mg. Eval.treatm. aft.6 mnths.
   treatm., control of ventric.respon.in pts.with supraventric. dysrhythm. if   Bradycard: 0,3-0,6 mg IV. This dos.may be incr. subseq. Check vol.  Contraindications: Urin./gastr.retent., uncontrol.narr.angle glauc.,
   pt.haemodynamic.compromis./tak. other meds.that decr.periph.resist./  to be admin.at time of extract. from amp.prior to inj.  myasth.grav., sev. ulcerat.colit., tox.megacolon., safety & effic.in
   myocard.fill./ myocard. contractil./electric.impulse propagat.in myo-  Contraindications: Prostat.enlargem., paralyt. ileus, pylor.stenos.,   childr.not est., safety in pregn.& lactat.not est.
   card., not recomm.in pts.already on ß-block. ther. as myocard.funct.  clos./narr.angle glauc., coron. insuffic./card.fail.  Side effects: Antimuscarin.effs.incl.dry mouth/ dyspeps./reduc.lacri-
   may be compromis., elderly, ren. decompensat., tachycard.respons.  Side effects: Dry mouth, pupil.dilat., incr.IOP, flush.& dry skin, tachy-  mat., bronchit., sinusit., allerg.reacts, CNS effs., vis.disturbs., vertigo,
   due to hypovolaem./ bld.loss dur./aft.surg.poss.obscur., myasth.grav.as   card., desire to urinate, constip., vomit., giddin., retrostern.pain, hy-  flush. skin, ., GI disturbs., gastro-oesophag.reflux, dry skin, dysur., urin.
   skelet.musc. weakn.poss. exacerbat., pts.with pheochromocyt.without   persens., ment.confus.  retent., chest pain, fatig., incr.weight., anaphylactoid reacts., psych.
   prior alpha-adrenerg.block.ther., not for use to treat hypertens. prim.due   Special precautions: Elderly males, tachycard. condits., fev.,   disords., tachycard., palpitat., angioed., periph. oed., dement.aggrav.
   to vasoconstrict.assoc.with hypotherm, pts.with bronchospast.dis, ter-  Downs’syndr., Parkinson.  in pts.tak.cholinesterase inhibit., prolongs QTc interv.
   min.ther. in case of bronchosp.& admin. ß 2 stimulat.agent if appropr.,   Drug interactions: Incr.eff.with some antihist., butyrophens.,   Warnings and special precautions: Urin. retent. risk, control.
   safety of dos.&gt;300 µg/kg/min not stud., reduc. dos./discont. in event   phenoth., TCA’s.  narr.angle glauc., decr.GI motility obstruct.disord.risks, ren./hepat.
   of adv.react., if loc. infus. site react.devel.use alternat infus.site & take   impairm., myasth. grav., autonom.neuropathy, hiatus hern., first
   caut.to prev.extravasat., avoid abrupt. discont. in coron.artery dis.pts.,   ATROPINE SULPHATE FRESENIUS AMPS, Fresenius Kabi [P/S]  excl.organ.caus.for urin.urgency, freq.&/or urge incontin., concom.
   hist.of sev. anaphylact. reacts.to variety of allerg.poss.more react. to   Atrop.sulph.  potent cytochrome P450 3A4 inhibit., adeq.contracept.in women
   repeat.chall.while treat.with beta-block. & may not respond to usual   Indications: Condits.requir.its parasympatholyt. eff., antidote in   of child-bear. potent., gastr.retent.risk, bladd.outflow obstruct., con-
   dos. of adrenal., avoid. concom. Ca-channel blocks in pts.with depress.   mushroom poison.
   myocard. funct., do not use to control SVT in pres. of vasoconstrict.&   (S4) INJ, [P/S] L/5.4/342, J/5.4/400.  genit./document.acquir.QT prolongat., pts.tak.Class 1A /class 111
                                                              antiarrhythm. meds.
   inotrop.agents eg.dopamine/ adrenal. /noradrenal., avoid concom.gen-  705551-008: 0,5 mg/ml, 10x1 ml, R56,65
   eral anaesth. caus.myocard.depress., safety in pregn.& lactat.not est.  705624-005: 0,6 mg/ml, 10x1 ml, R66,69  Drug interactions: More pronounc.therapeut.eff. & S/E with other
                                                              meds.with anticholinerg. propert., eff.reduc.by cholinerg.recept.ago-
   Interactions: Addit.& poss.excess.beta-adrenerg. block with reser-  (S4) INJ, [P/S] C1005
   pine, incr.conc.with warfarin, incr. bld. lev.of digoxin, incr.steady state   705578-003: 1 mg/ml, 10x1 ml amps, R56,96  nists, effs. of prokinet.decr., poss.interacts.with drugs metabol. by/
   bld.lev.with morphine, prolong.durat.of neuromusc.block. induc. by   Dosage: Premed: Admin.IM or SC. Adults: 0,3 -0,6 mg usual.in   inhibit.of cytochrome P450 2D6., incr. plasma conc.with concom.po-
   succinylcholine; anaphylact.reacts.to variety of allerg.poss.more re-  conjuct.with 10 -15 mg morph. sulph. about an hour bef.anaesthes.  tent cytochrome P450 3A4 inhibit., QTc interv.prolongat.with concom
   act.to repeat.chall.& may not respond to usual adrenal.dos., antidiab.   or 0,3-0,6 mg IV immed.bef.induct.of anaesthes. Paed.dos: Admin.   Class 1A/Class III antiarrhythm.meds.
   agents/sulfonylurea/insul.poss mask some hypoglycaem. sympts., va-  SC. Up to 3 kg: 0,1 mg. 7 -9 kg: 0,2 mg. 12 -16 kg: 0,3 mg.20 -27 kg:   DITROPAN, Sanofi-Aventis [P/S]
   soconstrict.& inotrop. agents eg dopamine/epinephr & norepinephr.  0,4 mg. 32 kg: 0,5 mg. 41 kg: 0,6 mg.  Oxybutynin HCl
   may block card.contractility when system.vasc.resist.is high, mutual   Post-op: Adults: Admin.slow IV 0,6 -1,2 mg in conjuct. with neostigmine.   Indications: Void.sympts.assoc.with uninhibit. neurogen.bladd.&
   inhibit.of therapeut. eff.with concom. aminophylline/ theophylline,   Arrhythm: Adults: Admin.IV 0,4 -1 mg repeat.as need.to max.2 mg.   reflex neurogen.bladd., spast neurogen.bladd., noct.enures.
   clear.of theophylline poss.decr.; metabol.poss.decr.by quinidine.  Bradycard./asystole due to parasympathomimet. OD: 1 -   (S3) TABS, L/5.4/104
                                2 mg IV/SC/IM                 720658-012: 5 mg, 100, R765,62
                                Anticholinesterase/organophosph.poison: Init: 2 - 4 mg IV if   Dosage: Adults: 1 tab.2-3xdly. Max.4xdly. Childr.over 5 yrs:
   5.3    Cholinergics          poss.(or IM) follow.by 2 mg every 5 -10 min.unt.muscar.sympt.disapp./  1 tab.2xdly. Max.3xdly.
                                signs of atrop. toxic.appear. More than 200 mg may be requir.on first
                                day. Mild degr.of atropine block should then be maint.for up to 48 hrs.  Contraindications: Clos.angle glauc., part./ compl.GIT obstruct.,
                                                              paralyt.ileus, intest.atony of elderly/debilitat.pts., megacol., tox.mega-
   MESTINON, MEDA Pharma [P/S]  Cholinerg.agonist intoxic: Admin.SC/IV 0,5 -1,0 mg.  colon complicat.ulcerat.colit., sev.colit., myasth.grav., obstruct.urop-
   Pyridostigmine Br            Cholinomimet.intoxic: Parent.admin.& adeq. meas.to support   athy, unstab.CV status in ac. haemorrh., hypoton.neurogen.bladd.,
   Indications: Myasth.grav.    resp., circulat.& counteract pulm.oed.
   (S4) TABS. UX/5.3/179, C/5.3/610  Mushroom poison: Admin.IM 1 - 2 mg every 30 mins.  safety in pregn.& lactat.not est., childr.und.5 yrs., prostat. enlargem.
                                                              Side effects: Anticholinerg.& CNS effs.incl. cognit.disords., GI
   742287-009: 10 mg, 50, R404,06  Contraindications: Clos.angle glauc., narr. angle betw.iris & cornea,
   742279-006: 60 mg, 150, R1 902,38  prostat.enlargem., paralyt.ileus, pylor.stenos., status asthmat., when   disturbs., tachycard., palpitat., vis.disords., urin.hesitan.& retent.,
                                                              decr.sweat., flush.& dryn.of skin, sev.aller.reacts./drug idiosyncr.
   Dosage: Indiv.titr.to eff. Adults: 1-3  60 mg tab.2-4xdly. High.dos.  ambient temp.is high esp.in childr., MAOI’s.
   may be requir.               Side effects: Pupil dilat., photophob., flush./dry skin, CV effs., diffic.  incl.urticar.& other derm.manifest., reduc. bronch.secret., lactat.
   Childr: 7 mg/kg bm dly.at 4 hrly.interv.  in micturit., reduc.tone & motilit. of GI tract., tolerance, vomit., sweat.,   suppress., impot.
   Contraindications: Mechan.intest./urin. obstruct., safety in   malaise & salivat.in parkinsonism pts.with sudd. withdr., confus.esp.in   Special precautions: Elderly men, high environm. temps., fev.,
   pregn.not est.               elderly, reduc.bronch.secret. poss.assoc.with format.of mucous plugs.  childr., tachycard.condits., card. surg., aggrav.sympt.of hyperthy-
   Side effects: Muscarin effs: GI disturbs., incr.salivat., incr. bronch.  Special precautions: Myasthen.grav., fev., coron.insuff., CF,   roid./coron. heart. dis./CHF/card.arrhythm.& hypertens., approp.
   secret., headache, mios., diaphores. Nicotic effs: musc.cramps, fas-  Down’s syndr., albinism, withdr. grad., childr. & elderly, ulcer.colit.,   diagnost.proced.& pre-treatm.exam.incl. cystometry rep.at interv.to
   ciculat., weakn. skin rash.  oesophag. sphinct. reflux exacerbat., diarrh., tachycard. condits.,   eval.respons., approp. antimicrob. ther.in pres.of infect., poss.intestin.
   Special precautions: Bronch.asthma, fail.to show. improvem.may   card. surg., ac.MI, hypertens.   obstruct. esp.in pts.with ileostomy/coloctomy., autonom. neuropathy,
   reflect und.-or overdos., S/E of antimusc. &/ nicotinic type usual.  Drug interactions: Eff.enhanc.by other medic. with parasympatho-  hepat./ren.dis., ulc.colit., hiatus hern.with reflux oesophagit., activ.
   manifest.if dos. too large/too freq., distinguish betw cholinerg. /my-  lyt.propert., reduct.in gastr. motil.poss.aff.absorpt.of other meds., ad-  req. ment. alertn.
   asthen.crisis, ren.dis., elderly, pre-exist. conduct.disturbs., concom.  dit. anticholinerg.eff.poss.with antipsychots., quinid.& disopyramide,   Drug interactions: Anticholinerg.eff.enhanc.by other agents
   kanamycin/ streptomycin /neomycin only when spec.indic.& with   incr.digoxin absorpt.  with anticholinerg.propert., reduc. gast.motil.poss.aff.absorpt.of
   caref.observ.to adjust anticholinesterase dos.             other meds.
   Drug interactions: Cert.antibiot.esp.neomycin/ kanamycin/strep-  DETRUNORM, Litha
   tomycin poss.accent.neuromusc. block.act.  Propiverine HCl  ENABLEX, (Aspen Pharmacare)
                                                              Pharmacare [P/S] &
   NEOSTIGMINE METHYLSULPHATE FRESENIUS AMPS,   Indications: Urin.incont./urgency & freq.in unstab. bladd.condits.,   Darifenacin
                                idiopath. bladd.instabil./ neurogen.bladd.from spin.cord inj.
   Fresenius Kabi [P/S]         (S3) TABS. 36/5.4/0019        Indications: Overact.bladd.with sympts.of urin. urgency, freq.&/
   Neostigmine methyl sulph.    703546-001: 15 mg, 30, R186,83  or urge incontin.
   Indications: Atony of GIT & urin.tract smooth musc., myasth.grav.,   Dosage: Adults incl.elderly: 1 tab.2 xdly. May be incr.to 3 xdly.   (S3) CR TABS, A38/5.4/0699, 0700
   terminat.of eff.of competit. neuromuscul.block.agents.  Some pts.respons on 15 mg dly.  706045-002: 7,5 mg, 14, R263,24
   (S4) INJ. C907, W/5.3/260    Reflex incontin: 1 tab 3 xdly incr.to 4 xdly if necess.&tol.  706045-001: 7,5 mg, 28, R526,49
   746649-002: 0,5 mg/ml, 10x1 ml amps, R55,92  (S3) XL CAPS, A40/5.4/0439  706046-001: 15 mg, 28, R526,49
   785636-005: 2,5 mg/ml, 10x1 ml amps, R108,36  720349-001: 30 mg, 28, R313,14  Dosage: Swallow whole, do not chew/divide or crush. Recomm.init.
   Dosage: Childr: 50 µg/kg bm.  Dosage: Adults incl.elderly: One cap.1x/day  dos: 7,5 mg dly. Dos.may be incr.to 15 mg dly.2 wks.aft.init.ther.bas.
   Paralyt.ileus, abdom.distent./dysuria: 0,5-1 mg SC/IM.  Contraindications: Bowel obstruct./susp., bladd. outflow obstruct.  on indiv. respons.& tol.if great.sympt.relief desir.
   Neuromusc.block.eff.terminat: 2-3 mg by slow IVI over 60 sec-  where urin.retent.poss.anticipat., myasth.grav., paralyt.ileus, intest.  Contraindications: Concom.potent.CYP3A4 inhibit.( e.g. ketocona-
   onds, addit.neostigmine may be given till musc.power is normal. To-  atony, sev. ulcerat. colit., tox.megacol., glauc., hepat.disords., ren./   zole, itraconazole/ miconazole/ troleandomycin/nefazadone/ ritona-
   tal of 5 mg not to be exceed. Concom.atrop.sulph.of 0,6-1,2 mg may   vir/nelfinavir & clarithromycin), urin./ gastric retent., uncontrol.narr.
   be given to control adverse eff.  impairm., tachydysrhythm., CF, diab.mellit. with autonom.dysfunct.,   angle glauc., sev. hepat.impairm., childr.und.18 yrs., pregn., lactat.,
                                pregn.& lactat., childr.due to lack of data,
   Myasth.grav: 1-2,5 mg dly SC/IM in div.dos.                Side effects: Dry mouth, constipat., abdom. pain, accid.injury, as-
   Contraindications: Mechan.intest./urin. obstruct., in conjunct.with   Side effects: Headache, trem., dizzin., dysgeus., mouth dryn., GI/  then., back/chest pain, halitos., oed., hernia, hot flush, pain, photo-
                                accomodat.disturbs., blurr./ abnorm. vis., decr.BP, drowsin., flush.,
   depolaris.musc.relax., dur. cyclopropane/ halothane anaesth., diab.,   sens., hypertens. & other CV effs., migraine, GI disturbs., stomatit.,
   gangr., peritonit., pregn.& lactat.  incr.resid. urine, tiredn., rash, hypersens., CNS/psych.eff., palpitat.,   leucopen., weight gain, musc.-skelet. disords., CNS effs., abnorm.
   Side effects: Salivat., anorex., N&V, abdom. cramps, diarrh., musc.  tachycard., liv.enzym.chang.  think., agitat., amnes., depress., extrapyramid.syndr., paraesthes.,
   cramps, fasciculat., weakn.  Warnings and special precautions: Monit. IOP/ hepat.enzym.  vertigo, rhinit.& other resp.disords., dry skin/rash & other skin re-
   Special precautions: Hyperthyroid., elderly, pre-exist.card.rhythm   dur.longt.ther., resid.urine vol.in UTI, autonom.neuropathy, rule out
   disturbs., imp.ren.funct., bronch. asthma, epilep., hypotens., Parkin-  urin.freq./ noctur. due to ren.dis./CHF as well as organ.bladd. dis.   acts., abnorm.vis., dry eyes, taste pervers., tinnit., urin.tract disords.,
                                                              urogenit.effs., menstr. disords., impot., vaginit.
   son., pept ulcerat., vagoton., poss.cholinerg.crisis in myasth. grav.  bef.start.treatm., contains gluc., condits poss. aggrav. incl. hyperthy-
   Drug interactions: Aminoglycosid., clindamycin, colistin., cycloprop.,   roid./coron.art.dis./CHF/card. dysrhythm./ tachycard./prostat.hyper-  Special precautions: Control.narr.angle glauc., mod.cytochrome
                                                              CYP3A4 inhibit., meds. predomin. metabolis.by CYP2D6 with narr.
   halog.anaesth., ß-adreno-block.agents, quinid., methyl pred., suxameth.  trophy/hiat. hern. with reflux oesophagit.& cerebr.scleros., lact.intol.
                                Interactions: CNS eff.enhanc.by sedat., incr. eff.withTCA’s/tran-  therapeut.window, mod.hepat.impairm.
                                quilis./other anticholinergs. /amantadine/neurolept.& ß-sympatho-  Drug interactions: Poss.incr.expos.to CYP2D6 substrates, ex-
                                                              pos.to digox.incr.
                                mimets., cholinergs. decr.eff., reduc.BP with isoniazid, eff.of meto-
   5.4    Anti-cholinergics     clopramide/cisapride.poss.decr.  See also MDR page 174.
          (See also 1.7.2, 12.3)  DETRUSITOL SR, Pfizer [P/S]  LENDITRO, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
   DETRUNORM (MDR Listing)      Tolterodine                   Oxybutynin
                                                              Indications: Void.sympts.assoc.with uninhibit. neurogen.& reflex
                                Indications: Overact.bladd.with sympts.of urin. urgency, freq.&/
   ENABLEX (MDR Listing)
   OXYREST (MDR Listing)        or urge incontin.             neurogen.bladd., spast. neurogen. bladd., noct.enures.
                                (S3) SR CAPS, 36/5.4/0448, 0449  (S3) TABS, 33/5.4/0411
   ADCO-ATROPINE, AI Crit.Care [P/S]  700862-001: 2 mg, 28, R499,96  872253-007: 5 mg, 20, R40,30
   Atropine sulph.              700871-001: 4 mg, 28, R499,96  872253-015: 5 mg, 100, R201,52</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page114.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page110.html">110</a>&nbsp;&nbsp;&nbsp;<a href="page111.html">111</a>&nbsp;&nbsp;&nbsp;<a href="page112.html">112</a>&nbsp;&nbsp;&nbsp;<a href="page113.html">113</a>&nbsp;&nbsp;&nbsp;<a href="page114.html">114</a>&nbsp;&nbsp;&nbsp;<a href="page115.html">115</a>&nbsp;&nbsp;&nbsp;<a href="page116.html">116</a>&nbsp;&nbsp;&nbsp;<a href="page117.html">117</a>&nbsp;&nbsp;&nbsp;<a href="page118.html">118</a>&nbsp;&nbsp;&nbsp;<a href="page119.html">119</a>&nbsp;&nbsp;&nbsp;<a href="page120.html">120</a>
             </td>
             <td width="35%"><a href="page116.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page116.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
